Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
ACS Chemical Neuroscience|January 12, 2016
Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat BrainChrista C Chrovian, Akinola Soyode-Johnson, Hong Ao, et al.ACS Medicinal Chemistry Letters|March 21, 2019
1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric ModulatorsChrista C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.Journal of Medicinal Chemistry|August 14, 2020
Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood DisordersChrista C Chrovian, Akinola Soyode-Johnson, Brice Stenne, et al.Journal of Medicinal Chemistry|February 9, 2023
Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric ModulatorsChristine F Gelin, Brice Stenne, Heather Coate, et al.Journal of Medicinal Chemistry|December 7, 2017
A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical CandidateChrista C Chrovian, Akinola Soyode-Johnson, Alexander A Peterson, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.Pageof 1